Comparative Pharmacology
Head-to-head clinical analysis: PLASMA LYTE 56 AND DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE M AND DEXTROSE 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: PLASMA LYTE 56 AND DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE M AND DEXTROSE 5 IN PLASTIC CONTAINER.
PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER vs PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Plasma-Lyte 56 and Dextrose 5% is a crystalloid solution that provides electrolytes and carbohydrates. Dextrose is metabolized to glucose, which is utilized for cellular energy production. The electrolytes (sodium, chloride, potassium, magnesium, and acetate) maintain or restore intravascular volume, acid-base balance, and osmotic gradients. Acetate is metabolized to bicarbonate, providing an alkalinizing effect.
Plasma-Lyte M and Dextrose 5% is an intravenous solution that provides electrolytes and calories. Dextrose is a monosaccharide that serves as a source of calories and water for cellular metabolism. Electrolytes (sodium, potassium, magnesium, chloride, acetate, gluconate) maintain fluid and electrolyte balance, and acetate and gluconate act as bicarbonate precursors to correct acidosis.
Intravenous infusion; dose depends on fluid and electrolyte requirements. Typical adult dose: 500-1000 mL as a single infusion, rate up to 333 mL/hour. Maximum 3 L/24 hours.
Intravenous infusion; adult dose determined by fluid and electrolyte needs; typical maintenance: 100-200 mL/hour (2-3 L/day) for normovolemic patients; adjust based on serum electrolytes, glucose, and clinical status.
None Documented
None Documented
Not applicable; composition-dependent. Dextrose half-life ~2 hours. Electrolytes follow endogenous regulation; no terminal elimination half-life defined.
Dextrose: <15 minutes (rapidly cleared from plasma); Electrolytes: No true half-life, as they are distributed and excreted according to homeostatic mechanisms.
Renal 100% (electrolytes and dextrose metabolized to CO2 and water; excess water and electrolytes excreted unchanged in urine).
Renal: 90% (as water and electrolytes); Dextrose is metabolized to CO2 and water, with negligible renal excretion of unchanged drug.
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution